Morningside Group

Morningside Group is an investment firm that was founded in 1986 and is based in Hong Kong, Hong Kong. The firm makes private equity and venture capital investments in the information technology, life sciences and clean technology sectors. It also participates in philanthropic activities to enable education, support science and fund medical research.

Morningside Group was founded by the Chan family of Hong Kong. The Chan family founded the Hang Lung Group in 1960. Today, the Hang Lung Group consists of Hang Lung Group Limited [0010.HK] and Hang Lung Properties Limited [0101.HK]. Both companies are listed on the Hong Kong Stock Exchange. Hang Lung Properties Limited is a constituent stock of the Hang Seng Index.

Morningside Group invests in private equity and venture capital opportunities in North America, Europe and Asia Pacific. Since 1992, China has increasingly become a significant part of the group's investment activities. Morningside Group has investments in the following sectors -- machinery manufacturing, high-tech, media, telecommunication, life science, education and clean technology. The group is managed by experienced investment professionals who are entrepreneurial, have deep industry knowledge and are effective in the local environment in which they operate.

Morningside Group's investments include Inotrem, MedAnnex, Aural Analytics, Apic Bio, Cashify, Agora.io, Liquidia Technologies, The Nue Co., Kuaidian Yuedu, Kezar Life Sciences and Desora.

Their exited investments include Xiaomi, ASLAN Pharmaceuticals, YY.com, Genocea Biosciences, Frequency Therapeutics, Apellis Pharmaceuticals, Aduro BioTech, Guazi Car Rental and Xunlei.